Salvage Cryotherapy for Recurrent PCa May Provide Long-Term Oncologic Control
Salvage cryotherapy is emerging as a viable local treatment option for prostate cancer that recurs following radiation treatment.
Cryoablation
Cryoablation Plus ADT for Newly Diagnosed Metastatic PCa Improves Outcomes
In a propensity score-based study, prostate cryoablation added to androgen deprivation therapy (ADT) improved failure-free survival and survival without castration-resistant disease compared with ADT alone.
Prostate Cancer Salvage Cryotherapy May Offer Durable Tumor Control
In a study, patients who underwent salvage cryotherapy for radiorecurrent prostate cancer had cancer-specific and metastasis-free survival rates of 81% and 78%, respectively, at 12 years.
Cryoablation Efficacious for Cancer Pain, Review Finds
Cryoablation also cuts the need for opioids at 24 hours post-treatment and at 3 months.
Focal vs Total PCa Cryoablation Better for Sexual Function
Oncologic outcomes are similar for focal and total cryoablation for localized prostate cancer, but patients report significantly better sexual function after focal cryoablation.
Data Support Biopsy Before Renal Cryo
The recurrence group had significantly larger tumors than the no-recurrence group.
Optimal PSA Nadir After Prostate Cryoablation Identified
A PSA nadir below 0.4 ng/mL offers the best long-term biochemical progression-free survival, study shows.
Cryotherapy Is a Viable Choice for High-Grade Prostate Cancer
Men who underwent whole-gland cryoablation had an estimated 5-year biochemical progression-free survival rate of 59.1%.
Salvage Cryo Outcomes Similar After EBRT, Brachytherapy
Study reveals comparable rates of freedom from biochemical failure at 5 years.
Survival Similar with Renal Cryo Techniques
Lapascopic and percutaneous cryoablation for small renal masses are associated with similar survival, researchers say.
- Loading...
Loading...
Loading... 
Loading...